Updates are available Correction dated 2025-08-01
Click to view Correction: https://doi.org/10.1038/s41591-025-03904-3
-
Authors
Miglino, Nicola
Toussaint, Nora C. https://orcid.org/0000-0001-7911-7647
Ring, Alexander
Bonilla, Ximena https://orcid.org/0000-0002-4950-6825
Tusup, Marina
Gosztonyi, Benedict
Mehra, Tarun https://orcid.org/0009-0005-8429-5110
Gut, Gabriele
Jacob, Francis https://orcid.org/0000-0002-0446-1942
Chevrier, Stephane
Lehmann, Kjong-Van
Casanova, Ruben
Jacobs, Andrea
Sivapatham, Sujana
Boos, Laura
Rahimzadeh, Parisa https://orcid.org/0000-0002-7192-9795
Schuerch, Manuel
Sobottka, Bettina
Chicherova, Natalia https://orcid.org/0000-0001-7899-0348
Yu, Shuqing
Wegmann, Rebekka https://orcid.org/0000-0001-9616-3303
Mena, Julien https://orcid.org/0000-0001-8040-810X
Milani, Emanuela S.
Goetze, Sandra https://orcid.org/0000-0001-6880-8020
Esposito, Cinzia
Sarabia del Castillo, Jacobo
Frei, Anja L.
Nowak, Marta
Irmisch, Anja
Kuipers, Jack
Baciu-Drăgan, Monica-Andreea
Ferreira, Pedro F.
Singer, Franziska https://orcid.org/0000-0002-6017-1595
Bertolini, Anne https://orcid.org/0000-0003-0691-0489
Prummer, Michael https://orcid.org/0000-0001-9896-3929
Lischetti, Ulrike
,
Ak, Melike
Al-Quaddoomi, Faisal S.
Albert, Silvana I.
Albinus, Jonas
Alborelli, Ilaria
Andani, Sonali
Attinger, Per-Olof
Baciu-Drăgan, Monica-Andreea
Baumhoer, Daniel
Beck-Schimmer, Beatrice
Bernasconi, Lara
Bosshard, Lars
Calgua, Byron
Chevrier, Stéphane
Coelho, Ricardo
D’Costa, Maya
Danenberg, Esther
Davidson, Natalie R.
Engler, Stefanie
Erkens, Martin
Eschbach, Katja
Fedier, André
Ficek-Pascual, Joanna
Frey, Bruno
Grob, Linda
Günther, Detlef
Haeuptle, Pirmin
Heinzelmann-Schwarz, Viola
Herter, Sylvia
Holtackers, Rene
Huesser, Tamara
Immer, Alexander
Jaeger, Tim M.
James, Alva R.
Jermann, Philip M.
Kahles, André
Kahraman, Abdullah
Kuebler, Werner
Kunze, Christian P.
Kurzeder, Christian
Levesque, Mitchell
Lombardo, Flavio C.
Lugert, Sebastian
Markolin, Philipp
Mehnert, Martin
Metzler, Julian M.
Muenst, Simone
Murri, Riccardo
Ng, Charlotte K. Y.
Nicolet, Stefan
Lopéz, Monica Nunez
Pedrioli, Patrick GA
Piscuoglio, Salvatore
Prélot, Laurie
Rimmer, Natalie
Ritter, Mathilde
Rommel, Christian
Rosano-González, María L.
Santacroce, Natascha
Schlenker, Ramona
Schwalie, Petra C.
Schwan, Severin
Schär, Tobias
Senti, Gabriela
Shao, Wenguang
Sreedharan, Vipin T.
Stark, Stefan
Stekhoven, Daniel J.
Tanna, Tanmay
Thomas, Tinu M.
Tolnay, Markus
Tosevski, Vinko
Tuncel, Mustafa A.
Van Drogen, Audrey
Vetter, Marcus
Vlajnic, Tatjana
Weber, Sandra
Weber, Walter P.
Wendt, Fabian
Wey, Norbert
Wildschut, Mattheus HE
Ziegler, Johanna
Zimmermann, Marc
Zoche, Martin
Zuend, Gregor
Aebersold, Rudolf https://orcid.org/0000-0002-9576-3267
Bacac, Marina
Maass, Gerd
Moch, Holger https://orcid.org/0000-0002-7986-2839
Weller, Michael https://orcid.org/0000-0002-1748-174X
Theocharides, Alexandre P. A.
Manz, Markus G. https://orcid.org/0000-0002-4676-7931
Beerenwinkel, Niko https://orcid.org/0000-0002-0573-6119
Beisel, Christian https://orcid.org/0000-0001-5360-2193
Pelkmans, Lucas
Snijder, Berend
Wollscheid, Bernd
Heinzelmann, Viola
Bodenmiller, Bernd https://orcid.org/0000-0002-6325-7861
Levesque, Mitchell P. https://orcid.org/0000-0001-5902-9420
Koelzer, Viktor H. https://orcid.org/0000-0001-9206-4885
Rätsch, Gunnar
Dummer, Reinhard https://orcid.org/0000-0002-2279-6906
Wicki, Andreas https://orcid.org/0000-0002-2924-8080
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 9 April 2025
First Online: 27 May 2025
Change Date: 1 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-025-03904-3
Competing interests
: B.B. is a founder and shareholder of Navignostics—a precision oncology spin-off from the University of Zurich—based on multiplexed imaging. L.P. is a founder and shareholder of Apricot Therapeutics - a precision oncology spin-off from the University of Zurich - based on 4i drug response profiling. V.H.K. reports being an invited speaker for Sharing Progress in Cancer Care (SPCC) and Indica Labs; advisory board of Takeda; sponsored research agreements with Roche and IAG, all unrelated to the current study. V.H.K. is a participant in patent applications on the assessment of cancer immunotherapy biomarkers by digital pathology and for the prediction of cancer recurrence risk and prediction of treatment efficacy using deep learning unrelated to the current study. G.G. and L.P. are listed as inventor on patents related to the 4i technology (WO 2019/207004; WO 2020/008071, EP3922973B1). R.D. received funding from Novartis, Merck Sharp & Dohme (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, T3 Pharma, MaxiVAX SA, Pfizer and Simcere. M.W. has received research grants from Novartis, Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Anheart, Bayer, Curevac, Medac, Neurosense, Novartis, Novocure, Orbus, Pfizer, Philogen, Roche and Servier. A.W. and R.D. were part of the MTB that discussed the TuPro results. The other authors declare no competing interests.
